• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SWATH-MS 技术在 miR-26a 敲除 HeLa 细胞中蛋白质表达变化的无标记定量分析。

Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.

机构信息

Hubei Collaborative Innovation Center for Green Transformation of Bio-resources, Hubei Key Laboratory of Industrial Biotechnology,school of Life Sciences, Hubei University, Wuhan, 430062, China.

Genecreate Biological Engineering Co., Ltd., National Bio-industry Base, Wuhan, 430071, Hubei, China.

出版信息

Sci Rep. 2019 Feb 4;9(1):1399. doi: 10.1038/s41598-018-34904-8.

DOI:10.1038/s41598-018-34904-8
PMID:30718521
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6362012/
Abstract

MicroRNAs (miRNAs) bind to the 3'-untranslated region of target mRNAs in a sequence-specific manner and subsequently repress gene translation. Human miR-26a has been studied extensively, but the target transcripts are far from complete. We first employed the CRISPR-Cas9 system to generate an miR-26a-knockout line in human cervical cancer HeLa cells. The miR26a-knockout line showed increased cell growth and altered proliferation. Proteomics technology of sequential window acquisition of all theoretical mass spectra (SWATH-MS) was utilized to compare the protein abundance between the wild-type and the knockout lines, with an attempt to identify transcripts whose translation was influenced by miR-26a. Functional classification of the proteins with significant changes revealed their function in stress response, proliferation, localization, development, signaling, etc. Several proteins in the cell cycle/proliferation signaling pathway were chosen to be validated by western blot and parallel reaction monitoring (PRM). The satisfactory consistency among the three approaches indicated the reliability of the SWATH-MS quantification. Among the computationally predicted targets, a subset of the targets was directly regulated by miR-26a, as demonstrated by luciferase assays and Western blotting. This study creates an inventory of miR-26a-targeted transcripts in HeLa cells and provides fundamental knowledge to further explore the functions of miR-26a in human cancer.

摘要

微小 RNA(miRNAs)以序列特异性的方式与靶 mRNA 的 3'-非翻译区结合,从而抑制基因翻译。人类 miR-26a 已经得到了广泛的研究,但靶转录本远未完全确定。我们首先利用 CRISPR-Cas9 系统在人宫颈癌 HeLa 细胞中生成 miR-26a 敲除系。miR26a 敲除系显示出细胞生长增加和增殖改变。我们利用顺序窗口采集所有理论质谱 (SWATH-MS) 的蛋白质组学技术来比较野生型和敲除系之间的蛋白质丰度,试图鉴定受 miR-26a 影响翻译的转录本。具有显著变化的蛋白质的功能分类揭示了它们在应激反应、增殖、定位、发育、信号转导等方面的功能。选择细胞周期/增殖信号通路中的几种蛋白质通过 Western blot 和平行反应监测 (PRM) 进行验证。这三种方法之间令人满意的一致性表明了 SWATH-MS 定量的可靠性。在计算预测的靶标中,一部分靶标被 miR-26a 直接调控,这通过荧光素酶测定和 Western blot 证实。这项研究在 HeLa 细胞中创建了 miR-26a 靶向转录本的清单,并为进一步探索 miR-26a 在人类癌症中的功能提供了基础知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/03cb3a23283f/41598_2018_34904_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/5b8acde8b0e0/41598_2018_34904_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/1a1eabbc58ea/41598_2018_34904_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/11a61598c78e/41598_2018_34904_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/c1187485ac9b/41598_2018_34904_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/10f5f2b71f8e/41598_2018_34904_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/3b0dfafd7cc6/41598_2018_34904_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/03cb3a23283f/41598_2018_34904_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/5b8acde8b0e0/41598_2018_34904_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/1a1eabbc58ea/41598_2018_34904_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/11a61598c78e/41598_2018_34904_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/c1187485ac9b/41598_2018_34904_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/10f5f2b71f8e/41598_2018_34904_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/3b0dfafd7cc6/41598_2018_34904_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2126/6362012/03cb3a23283f/41598_2018_34904_Fig7_HTML.jpg

相似文献

1
Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.SWATH-MS 技术在 miR-26a 敲除 HeLa 细胞中蛋白质表达变化的无标记定量分析。
Sci Rep. 2019 Feb 4;9(1):1399. doi: 10.1038/s41598-018-34904-8.
2
MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.微小RNA-26a通过靶向EZH2促进耐多西他赛肺腺癌细胞恶性行为的获得。
Cell Physiol Biochem. 2017;41(2):583-597. doi: 10.1159/000457879. Epub 2017 Feb 3.
3
miR-26a regulates mouse hepatocyte proliferation via directly targeting the 3' untranslated region of CCND2 and CCNE2.微小RNA-26a通过直接靶向细胞周期蛋白D2(CCND2)和细胞周期蛋白E2(CCNE2)的3'非翻译区来调节小鼠肝细胞增殖。
Hepatobiliary Pancreat Dis Int. 2016 Feb;15(1):65-72. doi: 10.1016/s1499-3872(15)60383-6.
4
miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.微小RNA-26a/b通过靶向胃癌中的肝细胞生长因子-血管内皮生长因子轴抑制肿瘤生长和血管生成。
Cell Physiol Biochem. 2017;42(4):1670-1683. doi: 10.1159/000479412. Epub 2017 Jul 24.
5
Quantitative proteomic analysis of gene regulation by miR-34a and miR-34c.miR-34a和miR-34c对基因调控的定量蛋白质组学分析
PLoS One. 2014 Mar 17;9(3):e92166. doi: 10.1371/journal.pone.0092166. eCollection 2014.
6
Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1.长链非编码 RNA SNHG5 通过靶向 ROCK1 海绵 miR-26a 促进骨肉瘤的发生。
Biomed Pharmacother. 2018 Nov;107:598-605. doi: 10.1016/j.biopha.2018.08.025. Epub 2018 Aug 14.
7
MiR-26a inhibits proliferation and migration of HaCaT keratinocytes through regulating PTEN expression.微小RNA-26a通过调控PTEN表达抑制HaCaT角质形成细胞的增殖和迁移。
Gene. 2016 Dec 5;594(1):117-124. doi: 10.1016/j.gene.2016.09.010. Epub 2016 Sep 6.
8
RNA G-quadruplex regulates microRNA-26a biogenesis and function.RNA G-四链体调节 microRNA-26a 的生物发生和功能。
J Hepatol. 2020 Aug;73(2):371-382. doi: 10.1016/j.jhep.2020.02.032. Epub 2020 Mar 10.
9
MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.微小RNA-26a通过靶向IVA1型蛋白酪氨酸磷酸酶抑制宫颈癌细胞的增殖和侵袭。
Mol Med Rep. 2014 Sep;10(3):1426-32. doi: 10.3892/mmr.2014.2335. Epub 2014 Jun 16.
10
MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.miR-26a 参与 Toll 样受体 9 介导的肺癌生长和迁移。
Int J Mol Med. 2014 Jul;34(1):307-12. doi: 10.3892/ijmm.2014.1764. Epub 2014 Apr 30.

引用本文的文献

1
Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation.胰腺癌细胞利用肿瘤抑制性微小RNA-26a来促进放射抗性并增强肿瘤再增殖。
Heliyon. 2024 May 15;10(10):e31346. doi: 10.1016/j.heliyon.2024.e31346. eCollection 2024 May 30.
2
Interfering Human Papillomavirus E6/E7 Oncogenes in Cervical Cancer Cells Inhibits the Angiogenesis of Vascular Endothelial Cells via Increasing miR-377 in Cervical Cancer Cell-Derived Microvesicles.干扰人乳头瘤病毒E6/E7癌基因在宫颈癌细胞中通过增加宫颈癌细胞衍生微泡中的miR-377来抑制血管内皮细胞的血管生成。
Onco Targets Ther. 2020 May 13;13:4145-4155. doi: 10.2147/OTT.S239979. eCollection 2020.

本文引用的文献

1
MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma.微小RNA-3613-3p影响肝细胞癌的细胞增殖和细胞周期。
Oncotarget. 2017 Oct 10;8(54):93014-93028. doi: 10.18632/oncotarget.21745. eCollection 2017 Nov 3.
2
miR-6883 Family miRNAs Target CDK4/6 to Induce G Phase Cell-Cycle Arrest in Colon Cancer Cells.miR-6883 家族 miRNA 通过靶向 CDK4/6 诱导结肠癌细胞 G1 期细胞周期停滞。
Cancer Res. 2017 Dec 15;77(24):6902-6913. doi: 10.1158/0008-5472.CAN-17-1767. Epub 2017 Oct 23.
3
Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma.
口腔疣状癌中 miRNA-195 及其靶基因 CDK6 的研究。
Cancer Gene Ther. 2017 Jul;24(7):282-288. doi: 10.1038/cgt.2017.18. Epub 2017 Jun 16.
4
miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.微小RNA-186通过靶向YY1和CDK6抑制前列腺癌细胞增殖和肿瘤生长。
Exp Ther Med. 2017 Jun;13(6):3309-3314. doi: 10.3892/etm.2017.4387. Epub 2017 Apr 26.
5
MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling, the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection.微小RNA 26a(miR-26a)/KLF4以及CREB-C/EBPβ在感染过程中调节固有免疫信号、巨噬细胞极化以及结核分枝杆菌向溶酶体的转运。
PLoS Pathog. 2017 May 30;13(5):e1006410. doi: 10.1371/journal.ppat.1006410. eCollection 2017 May.
6
MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.微小RNA-329-3p靶向丝裂原活化蛋白激酶1以抑制宫颈癌中的细胞增殖、迁移和侵袭。
Oncol Rep. 2017 May;37(5):2743-2750. doi: 10.3892/or.2017.5555. Epub 2017 Apr 5.
7
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with mutations.核糖体蛋白基因的缺失是人类癌症中的一种常见脆弱性,尤其是与突变共同作用时。
EMBO Mol Med. 2017 Apr;9(4):498-507. doi: 10.15252/emmm.201606660.
8
Proteasome inhibitors in cancer therapy.蛋白酶体抑制剂在癌症治疗中的应用。
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433. doi: 10.1038/nrclinonc.2016.206. Epub 2017 Jan 24.
9
Phosphorylation: Implications in Cancer.磷酸化:对癌症的影响
Protein J. 2017 Feb;36(1):1-6. doi: 10.1007/s10930-017-9696-z.
10
CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells.CRISPR-Cas9介导的NOX4基因敲除抑制HeLa细胞的增殖和侵袭
PLoS One. 2017 Jan 18;12(1):e0170327. doi: 10.1371/journal.pone.0170327. eCollection 2017.